Ohio Public Employees Retirement System (OPERS)’s Denali Therapeutics DNLI Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-28,040	Closed	-$827K	–	1975
2023 Q2	$827K	Buy	28,040 +15,769	+129%	+$443K	﹤0.01%	1192
2023 Q1	$283K	Buy	12,271 +6,020	+96%	+$166K	﹤0.01%	1351
2022 Q4	$174K	Buy	+6,251	New	+$186K	﹤0.01%	1415
2021 Q3	–	Sell	-20,201	Closed	-$1.58M	–	1995
2021 Q2	$1.58M	Hold	20,201	–	–	0.01%	1189
2021 Q1	$1.15M	Hold	20,201	–	–	﹤0.01%	1211
2020 Q4	$1.69M	Buy	+20,201	New	+$1.22M	0.01%	1057

Other funds holding DNLI

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s DNLI Position: Q3 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Denali Therapeutics (DNLI) in Q3 2023, closing a stake of 28,040 shares — an estimated $827K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in DNLI in Q4 2020 and held it in 6 quarters. The position peaked at $1.69M in Q4 2020. 194 funds tracked by Wall St. Rank hold DNLI as of Q3 2023.

Ohio Public Employees Retirement System (OPERS) reported no remaining Denali Therapeutics position as of Q3 2023 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 28,040 Denali Therapeutics shares in Q3 2023, an estimated $827K.
Ohio Public Employees Retirement System (OPERS) first reported a position in Denali Therapeutics in Q4 2020 and held it in 6 quarters.
Ohio Public Employees Retirement System (OPERS)'s Denali Therapeutics position peaked at $1.69M in Q4 2020.
194 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q3 2023, filed 15 Nov 2023.